Detalhe da pesquisa
1.
Efficacy and safety of abrocitinib in patients with moderate-to-severe atopic dermatitis and comorbid allergies.
Allergy
; 79(1): 174-183, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988255
2.
A novel recycling mechanism of native IgE-antigen complexes in human B cells facilitates transfer of antigen to dendritic cells for antigen presentation.
J Allergy Clin Immunol
; 142(2): 557-568.e6, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29074459
3.
Health-Related Quality of Life Outcomes With Tofacitinib Treatment in Patients With Ulcerative Colitis in the Open-Label Extension Study, OCTAVE Open.
Inflamm Bowel Dis
; 29(9): 1370-1379, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36242764
4.
Corticosteroid-free efficacy and safety outcomes in patients receiving tofacitinib in the OCTAVE Sustain maintenance study.
Therap Adv Gastroenterol
; 15: 17562848221090834, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35574426
5.
Extraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.
Therap Adv Gastroenterol
; 14: 17562848211005708, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34035832
6.
High affinity targeting of CD23 inhibits IgE synthesis in human B cells.
Immun Inflamm Dis
; 3(4): 339-49, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26732048